Fasco M J, Hildebrandt E F, Suttie J W
J Biol Chem. 1982 Oct 10;257(19):11210-2.
The dithiothreitol-dependent vitamin K and vitamin K 2,3-epoxide hepatic microsomal reductase activities of warfarin-susceptible and warfarin-resistant rats were compared to gain insight into the role(s) of these activities in vitamin K metabolism and function. In microsomes from resistant rats, 3- to 4-fold more warfarin was required to produce 50% inhibition (I50) of vitamin K reduction to vitamin K hydroquinone than in microsomes from susceptible rats. For the reduction of vitamin K 2,3-epoxide to vitamin K a 6-fold higher warfarin concentration was required. In microsomes from resistant rats, the I50 warfarin concentration required to inhibit gamma-carboxylation of microsomal precursor protein was also 4-fold higher with vitamin K as substrate and was 6-fold higher with the epoxide as substrate than in microsomes from susceptible rats. Collectively, these data suggest that the vitamin K reductase contributes to the metabolism of vitamin K in intact rats and that warfarin inhibition of both the vitamin K and vitamin K 2,3-epoxide reductases is involved in its anticoagulant effect.
比较了对华法林敏感和耐药大鼠的二硫苏糖醇依赖性维生素K及维生素K 2,3-环氧化物肝微粒体还原酶活性,以深入了解这些活性在维生素K代谢和功能中的作用。在耐药大鼠的微粒体中,与敏感大鼠的微粒体相比,将维生素K还原为氢醌产生50%抑制(I50)所需的华法林量要多3至4倍。将维生素K 2,3-环氧化物还原为维生素K所需的华法林浓度要高6倍。在耐药大鼠的微粒体中,以维生素K为底物时,抑制微粒体前体蛋白γ-羧化所需的I50华法林浓度也比敏感大鼠的微粒体高4倍,以环氧化物为底物时则高6倍。总体而言,这些数据表明维生素K还原酶有助于完整大鼠体内维生素K的代谢,并且华法林对维生素K和维生素K 2,3-环氧化物还原酶的抑制作用都与其抗凝作用有关。